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Available online xxxxBackground: Prefrontal cortex gyriﬁcation has been suggested to be altered in patients with schizophrenia and
ﬁrst episode psychosis. Therefore, it may represent a possible trait marker for these illnesses and an indirect ev-
idence of a disrupted underlying connectivity. The aim of this study was to add further evidence to the existing
literature on the role of prefrontal gyriﬁcation in psychosis by carrying out a study on a sizeable sample of chronic
patients with schizophrenia and non-affective ﬁrst-episode psychosis (FEP-NA) patients.
Methods: Seventy-two patients with schizophrenia, 51 FEP-NA patients (12 who later develop schizophrenia)
and 95 healthy controls (HC) underwent magnetic resonance imaging (MRI). Cortical folding was quantiﬁed
using the automated gyriﬁcation index (GI). GI values were compared among groups and related to clinical var-
iables.
Results: Both FEP-NA and patients with schizophrenia showed a higher mean prefrontal GI compared to HC
(all p b 0.05). Interestingly, no differences have been observed between the two patients groups as well as
between FEP-NA patients who did and did not develop schizophrenia.
Conclusions: Our results suggest the presence of a shared aberrant prefrontal GI in subjects with both
schizophrenia and ﬁrst-episode psychosis. These ﬁndings support the hypothesis that altered GI represents
a neurodevelopmental trait marker for psychosis, which may be involved in the associated neurocognitive
deﬁcits.
© 2017 Elsevier B.V. All rights reserved.Keywords:
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MRI1. Introduction
Several studies consistently support the evidence that brain
disconnectivity plays a key role in the pathophysiology of schizophrenia
(Friston and Frith, 1995; Friston, 2002; Schmitt et al., 2011; White and
Hilgetag, 2011), with particular regards to prefrontal cortex (PFC)
(Rubinov and Bullmore, 2013; Zhou et al., 2015; Wheeler and
Voineskos, 2014). In particular, the tension exerted by the viscoelastictale e Neuroscienze, Università
Cà Granda Ospedale Maggiore
lla).
creased gyriﬁcation in schiz
17.06.060nerve ﬁbers is thought to inﬂuence cortical folding (Van Essen, 1997),
with literature documenting that alterations in connectivity may lead
to an altered cortical folding (Rakic, 1988; Konrad and Winterer, 2008;
White et al., 2010).
In general, cortical folding has been considered an early
neurodevelopmental process, which occur prior to birth and continuing
into childhood (White et al., 2010; Garel et al., 2001). Importantly, this
process is responsible for the correct development of convolution pat-
terns and cortical organization through its associationwithmyelination,
synaptogenesis and pruning (Casey et al., 2005; White et al., 2010).
In this context, the investigation of cortical folding in schizophrenia
might be of paramount importance, especially due to the
neurodevelopmental origins of this disabling psychiatric illness (Owen
et al., 2011). Indeed, it has been proposed that abnormal gyriﬁcation,ophrenia and non affective ﬁrst episode of psychosis, Schizophr. Res.
2 R. Zuliani et al. / Schizophrenia Research xxx (2017) xxx–xxxwhich provides an index of degree and pattern of folding of brain cortex
and an indirect sign of altered connectivity, represents a brain marker
for schizophrenia (White and Gottesman, 2012). In this regard, the
Gyriﬁcation Index (GI), whichmeasures the ratio of the exposed cortical
surface to the cerebral hull (Moorhead et al., 2006; Zilles et al., 1989), is
among themost reliable methods used to quantify surface morphology.
In this perspective, it has been shown that the PFC is a core structure
consistently found to be associated with schizophrenia, as reported by
several functional (Zhou et al., 2015) and structural (Levitt et al.,
2010; Castellani et al., 2012) neuroimaging studies. Indeed, the PFC
has been found to be associated with selective deﬁcits in speciﬁc cogni-
tive domains, including working memory, executive functions and at-
tention, abilities often found to be impaired in schizophrenia (Arnsten,
2011; Pratt et al., 2008; Nenadic et al., 2012; Brambilla et al., 2013a,
2013b). Additionally, in schizophrenia, PFC alterations have been also
reported to be associated with positive and negative symptoms
(Der-Avakian and Markou, 2012; Goghari et al., 2010; Nenadic et al.,
2012; Delvecchio et al., 2017a). Therefore, the investigation of abnormal
GI in this structure represents a window for deepen our knowledge on
whether PFC deﬁcits occur earlier during brain development. Nonethe-
less, the evidence reporting the role of prefrontal cortical folding in
schizophrenia have led to contrasting results (White and Hilgetag,
2011). Indeed, although PFC hypergyria has been reported in patients
suffering from schizophrenia (Falkai et al., 2007; Vogeley et al., 2001;
Nenadic et al., 2015), other authors have, in contrast, reported
hypogyria (Bonnici et al., 2007; Cachia et al., 2007; Kulynych et al.,
1997; Mancini-Marie et al., 2015; McIntosh et al., 2009; Nesvag et al.,
2014; Palaniyappan et al., 2011; Palaniyappan and Liddle, 2012;
Tepest et al., 2013) or no abnormalities (Highley et al., 2003). Similarly,
the same mixed picture have been reported in ﬁrst-episode patients
with schizophrenia (Narr et al., 2004; Janssen et al., 2014; Wiegand et
al., 2005), while only one study has investigated cortical gyriﬁcation in
non-affective ﬁrst-episode psychosis (FEP-NA) (Palaniyappan et al.,
2013), showing hypogyria in the PFC.
Therefore, our study aimed at better clarifying the role of abnormal
prefrontal gyriﬁcation in psychosis by carrying out a study on a sizeable
sample of patients with FEP-NA and with chronic patients with schizo-
phrenia. Based on previous evidence, we hypothesized that patients
with schizophrenia would show abnormally folded PFC compared to
healthy controls (HC), although the direction of this disruption is still
not well elucidated. Moreover, by extending the analyses to FEP-NA pa-
tients we are in the position to explore, and to further clarify, whether
altered PFC gyriﬁcation can be considered an early distinctive marker
for psychosis and, in turn, an indirect sign of a altered underlying
connectivity.
2. Methods
2.1. Participants
The sample included 51 FEP-NA, 72 patientswith schizophrenia, and
95 HC. All subjects gave signed informed consent. Patients with FEP-NA
were recruited within the PICOS project, which has been extensively
previously described by our group (Lasalvia et al., 2012). In order to
be eligible for the PICOS project only psychopathological criteria were
used and the over-inclusive screening methodology of the WHO ten-
country study (Screening Schedule for Psychosis; Jablensky et al.,
1992) was adopted. For FEP-NA patients, the inclusion criteria were:
(1) presence of (a) at least one of the following symptoms: hallucina-
tions, delusions, qualitative speech disorder, qualitative psychomotor
disorder, bizarre or grossly inappropriate behavior, or (b) at least two
of the following symptoms: loss of interest, initiative and drive, social
withdrawal, episodic severe excitement, purposeless destructiveness,
overwhelming fear, marked self-neglect; (2) ﬁrst lifetime contact
with any mental health service located in PICOS area during the study
period resulting from symptoms listed in (1). The exclusion criteriaPlease cite this article as: Zuliani, R., et al., Increased gyriﬁcation in schiz
(2017), http://dx.doi.org/10.1016/j.schres.2017.06.060for FEP-NA patients were: (1) prior treatment with an antipsychotics
for N3months; (2)mental disorders due to a generalmedical condition;
(3)moderate to severemental retardation. The formal best-estimate di-
agnosis wasmade six months after the recruitment. Among the FEP-NA
patients, 12 had later develop schizophrenia and met the following di-
agnoses: Paranoid schizophrenia (n= 10) and Undifferentiated schizo-
phrenia (n = 2). The remaining 39 FEP-NA patients who did not
develop schizophreniawere diagnosedwith: Acute transitory psychosis
(n = 13), Non-organic, non-speciﬁc psychosis (n = 11), Persistent de-
lusional psychotic syndrome (n = 7), Schizoaffective syndrome (n =
6), Acute delusional syndrome (n = 1), Acute psychosis with schizo-
phrenic symptoms (n = 1). Patients with schizophrenia eligible for
the study were selected by means of the South-Verona Psychiatric
Care Register (PCR) (Tansella and Burti, 2003), a community-based
mental health register, as previously reported in our publications
(Delvecchio et al., 2017a, 2017b; Brambilla et al., 2013a, 2013b). They
had chronic illness. Speciﬁcally, the majority of them had residual
schizophrenia and were clinically stable (N = 43) whereas the others
were either in the acute phase or in remission after an acute episode.
For both patients with schizophrenia and FEP-NA patients, a formal
ICD-10 diagnosis was assessed by using the Item Group Checklist
(IGC) of the Schedule for Clinical Assessment in Neuropsychiatry
(SCAN) (World Health Organization, 1992). Two psychiatrists indepen-
dently reviewed the relevant information and formulated the ICD-10di-
agnosis. In the cases the consensus was not reached, the opinion of a
third psychiatrist was solicited to clarify diagnostic problems. A non-
parametric Mann-Withney U test was performed for comparing GI
values, Intra Cranial Volumes (ICVs) and age of FEP-NA who did (N =
12) and did not (N = 39) develop schizophrenia. The results showed
that the merging of the two sub-groups in a unique group of FEP-NA
was possible. Speciﬁcally, no differences emerged in GI and ICV (p N
0.1). Instead there was a signiﬁcant age difference (mean age ± SD for
FEP-NA who did and did not develop schizophrenia was 30.52 ± 8.75
and 40.22 ± 11.82 respectively). The potential effect of age on the var-
iable of interest (i.e. GI) was, in any case, factored out in the following
analyses as it was entered as covariate. The clinical symptomatology
of all patients was evaluated using the 24 item Brief Psychiatric Rating
Scale (BPRS) (Overall and Gorham, 1962). Moreover, alcohol or sub-
stance abuse was assessed with two speciﬁc item sections (sections 11
and 12) of the SCAN. All patients with schizophrenia and FEP-NA pa-
tients with other Axis I disorders, alcohol or substance abuse, history
of traumatic head injury with loss of consciousness, epilepsy or other
neurological or medical diseases, including hypertension and diabetes,
were excluded from the study. Patients' medication was recorded and
chlorpromazine equivalent dosages were calculated.
HC were recruited through word of mouth and advertisements in
the geographically deﬁned catchment area of South Verona. They had
no history of head injury or psychiatric Axis I disorder, determined
using a brief modiﬁed version of the Structured Clinical Interview for
DSM-IV- Non patient version, no history of psychiatric disorder among
ﬁrst-degree relatives, no history of alcohol or substance misuse and no
current major medical illness. The demographic and clinical details are
presented in Table 1.
2.2. Magnetic resonance imaging (MRI) protocol
Magnetic resonance scans were acquired with a 1.5 T Siemens Mag-
neton Symphony Maestro Class scanner, Syngo MR, 2002B (Siemens,
Erlagen, Germany). A standard head coil was used for radio-frequency
transmission and reception of the magnetic resonance signal;
restraining foam pads were used to minimize head motion. First, T1-
weighted images were obtained to verify each participant's head posi-
tion and the image quality, with acquisition parameters repetition
time (TR) 450 ms, time to echo (TE) 14 ms, ﬂip angle 90°, ﬁeld of
view (FOV) 230 × 512 mm2, 18 slices, slice thickness 5 mm, matrix
size 384 × 512, number of excitations (NEX) 2. Proton density and T2-ophrenia and non affective ﬁrst episode of psychosis, Schizophr. Res.
Table 1
Demographic and clinical characteristics of the three groups.
FEP-NA SCH HC Statistics
Number of subjects 51 72 95
Age, mean ± SD (range) (yrs) 30.52 ± 8.75
(18.2–57.8)
40.22 ± 11.82
(18.53–62.19)
39.14 ± 11.59
(20.33–61.49)
Univariate ANOVA
Main effect of group; F(2, 215) = 13.33, p b 0.001
Post-hoc comparisons
HC vs FEP; p b 0.001⁎
HC vs SCZ; p = 1.0
FEP vs SCZ; p b 0.001⁎
Male/female 21/30 26/46 48/47 HC vs FEP; χ2 = 1.164, p = 0.281
HC vs SCZ; χ2 = 3.449, p = 0.063
FEP vs SCZ; χ2 = 0.324, p = 0.569
Intra cranial volume (ICV)
Mean ± SD (range)
1466.95 ± 133.23
(1206.99–1720.05)
1476.29 ± 163.35
(1099.25–1862.62)
1457.21 ± 140.85
(1092.20–1888.62)
Univariate ANOVA
Main effect of group; F(2, 215) = 0.35, p = 0.71
Post-hoc comparisons
HC vs FEP; p = 1.0
HC vs SCZ; p = 1.0
FEP vs SCZ; p = 1.0
Age of onset, mean ± SD (range) (yrs) 28.6 ± 7.5
(16–52)
26.31 ± 9.1
(15–58)
Duration of illness, mean ± SD (range) (yrs) 2.02 ± 2.9
(0–18)
13.99 ± 10.7
(0,5–43)
Medications Atypical: 25
Typical: 11
Unmedicated: 14
Atypical: 45
Typical: 26
Unmedicated: 1
AP lifetime, mean ± SD (range) (yrs) 1.45 ± 3.1
(0,33–18)
11.82 ± 10.3
(0–43)
Chlorpromazine equivalents, mean ± SD (range) 11 ± 33
(0−200)
215 ± 165
(25–600)
BPRS positive symptoms, mean ± SD (range) 6.2 ± 1.5
(5–12)
11.5 ± 6.2
(5–32)
BPRS negative symptoms, mean ± SD (range) 8.6 ± 2.4
(7–18)
11.6 ± 4.6
(7–35)
BPRS total score, mean ± SD
(range)
31.3 ± 6.3
(24–50)
44.8 ± 18
(24–125)
FEP-NA = First Episode Non Affective Psychosis; HC = healthy controls; SCH = patients with schizophrenia; AP = antipsychotics; BPRS = Brief Psychiatric Rating Scale.
⁎ N represents the number of fatalities.
3R. Zuliani et al. / Schizophrenia Research xxx (2017) xxx–xxxweighted images were then acquired (TR= 2500ms, TE= 24/121 ms,
ﬂip angle 180°, FOV = 230 × 230 mm2, 20 slices, slice thickness 5 mm,
matrix size 410 × 512, NEX 2) according to an axial plane parallel to the
anterior–posterior commissures to exclude focal lesions. Subsequently,
a coronal 3D magnetisation prepared rapid gradient echo (MP-RAGE)
sequence was acquired (TR = 2060 ms, TE = 3.9 ms, ﬂip angle 158°,
FOV = 176 × 235 mm2, slice thickness 1.25 mm, matrix size 270
× 512, TIME 1100 ms) to obtain 144 images covering the entire brain.
2.3. Image processing
The cortical folding and tissuemeasures were extracted using a reli-
able automated GI methodology, already described elsewhere (Bonnici
et al., 2007;Moorhead et al., 2006). Brieﬂy, the automated GI tool works
through several stages. First, the whole brains were preprocessed by
using the image pre-processing functions from the SPM package
(http://www.ﬁl.ion.ucl.ac.uk/spm/) (Ashburner and Friston, 2000).
Speciﬁcally, the T1 scans were reoriented in native space along the an-
terior–posterior commissure and resliced to give a voxels size of 1 mm
× 1 mm × 1 mm. Then, the brain images were segmented in native
space by using a speciﬁc template previously created for this cohort
(Moorhead et al., 2006).
With regard to prefrontal lobe detection, the automated GI tool pro-
vides an automated parcellation procedure which detect the anterior
limit of the corpus callosum and the inter-hemispheric ﬁssure, crucial
for splitting the lobes and extracting the prefrontal lobe. Moreover, in
order to calculate GI the inner and outer contours of the prefrontal
lobe should be calculated. Speciﬁcally, the automated GI inner contour
is traced along the entire surface of the brain. Buried sulci (i.e. those
that do not communicate directly with the cortical surface on that par-
ticular slice) are also included. The inner contour is measured as a con-
tinuous unbroken line. The outer contour is extracted from the brainPlease cite this article as: Zuliani, R., et al., Increased gyriﬁcation in schiz
(2017), http://dx.doi.org/10.1016/j.schres.2017.06.060outline and the inter-hemisphere ﬁssure cleave in each coronal slice,
as suggested by Zilles et al. (1989). The results are then exported and
the prefrontal GI calculated by dividing the inner by the outer contour.
Results were given for each subject, left and right hemisphere separate-
ly, for theﬁrst 30 slices of the prefrontal lobe. The GI valueswere obtain-
ed averaging the 30 slices. For each subject the extracted prefrontal
lobes are used to recover the gray, white and cerebrospinal ﬂuid (CSF)
tissue volumes from the SPM native space segmentations. The GI trace
in each scan was qualitatively reviewed (not edited) by the principal
and fourth author who were blind to group membership.2.4. Statistical analyses
Preliminary analyses were performed in order to obtain a better de-
scription of the three groups and to decide which covariates had to be
entered into the main analyses. To this aim, we carried out two univar-
iate ANOVAs with group (FEP-NA, patients with schizophrenia and HC)
asﬁxed factor and age or ICV as dependent variables, to explore the pos-
sible differences between groups for those variables. Moreover, χ2 tests
were used to check whether the three groups differed for the propor-
tions of males and females.
Finally, the GI values were entered as dependent variable in a 2 × 3
repeatedmeasures ANOVAwith hemisphere (left, right) as “within sub-
ject” factor and group (FEP-NA, patients with schizophrenia, HC) as “be-
tween subject” factor. Three more 2 × 2 repeated measures ANOVAs,
with hemisphere (left, right) as “within subject” factor, group (FEP-NA
vs HC; patients with schizophrenia vs HC; FEP-NA vs patients with
schizophrenia) as “between subject” factor, were performed to clarify
themain effect of group. Age was entered as covariate in all themodels.
Pearson's correlations examined the possible relationship between GI,
gender, age, ICV and clinical measures.ophrenia and non affective ﬁrst episode of psychosis, Schizophr. Res.
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FEP-NA, patients with schizophrenia and HC did not differ for ICV
and for the proportion of males and females within each group (all χ2
b 3.3, all p N 0.03). Unsurprisingly, the FEP-NA patients were signiﬁcant-
ly younger than the other two groups (all p b 0.001) (Table 1).
3.1. GI - repeated measures ANOVA
Refer to Table 2 for the means and standard deviations of the GI, as
well as for the statistical values obtained from the analyses. The 2× 3 re-
peated measures ANOVA showed a main effect of the hemisphere with
the left hemisphere generally having a higher GI than the right. Also the
main effect of the group was signiﬁcant. No signiﬁcant group x hemi-
sphere interaction was observed. The 2 × 2 repeatedmeasures ANOVAs
comparing two groups at a time highlighted a signiﬁcant difference be-
tween FEP-NA and HC, as well as between patients with schizophrenia
andHC,with FEP-NA andpatientswith schizophrenia both having a sig-
niﬁcantly higher GI than HC. Instead, no differences were found be-
tween FEP-NA and patients with schizophrenia. Coherently with the 2
× 3 overall ANOVA, the three 2 × 2 ANOVAs reported a main effect of
the hemisphere and a lack of a hemisphere x group interaction.
3.2. Correlations with clinical variables
No signiﬁcant correlations were observed between GI values and
ICV, gender or with the other clinical variables, such as age of onset, du-
ration of illness, lifetime treatment with antipsychotic, chlorpromazine
equivalents and BPRS scores (Pearson's correlation analyses, p N 0.05).
4. Discussion
In this study we provided further evidence of an altered prefrontal
cortical folding in schizophrenia. Additionally, alterations in GI patterns
were present in non-affective patients at their ﬁrst psychotic episode. In
particular, both groups had higher prefrontal GI relative to HC, whereas
no differences between subjects with schizophrenia and those with
FEP-NA were detected.
Speciﬁcally for schizophrenia, our results are consistent with previ-
ous ﬁndings showing hypergyria within the PFC (Falkai et al., 2007;
Vogeley et al., 2001; Nenadic et al., 2015). However, other studies re-
ported hypogiria or preserved GI in the PFC of patients with schizophre-
nia (Bonnici et al., 2007; Cachia et al., 2007; Kulynych et al., 1997;
Mancini-Marie et al., 2015; McIntosh et al., 2009; Nesvag et al., 2014;
Palaniyappan and Liddle, 2012; Palaniyappan et al., 2011; Tepest et al.,
2013; Highley et al., 2003). Possible explanations for these contrasting
results could be related to the relative small sample size or to the pres-
ence of discrepancy between males and females within the patients or
the control group. In this regard, it has been reported that gender-Table 2
Comparison of Gyriﬁcation Index (GI) values for the three groups. Values are reported for left an
the main effect for p b 0.05*. Signiﬁcance of the comparisons between FEP-NA and HC, SCH an
GI mean values 2 × 3 repea
Right hemisphere (mean; SD) 2.22 ± 0.12 Group
Left hemisphere (mean; SD) 2.32 ± 0.12 F(2, 214) =
2 × 2 repea
HC FEP-NA SCH FEP-NA vs H
Main effect
Right hemisphere (mean; SD) 2.19 ± 0.11 2.24 ± 0.12 2.25 ± 0.10 F(1, 143) =
Left hemisphere (mean; SD) 2.30 ± 0.13 2.34 ± 0.12 2.35 ± 0.11
FEP-NA = Non-affective ﬁrst-episode psychosis patients; SCH= patients with schizophrenia;
hemispherewas signiﬁcant (all p b 0.02)while the interaction group×hemispherewas not sign
of the 2 × 2 repeated measures ANOVAsmirrored the ﬁndings of the main 2 × 3 repeated mea
regardless the Group [FEP-NA vs HC - Hemisphere F(1, 143) = 24.15, p b 0.001, Group × Hemi
Group × Hemisphere F(1, 164) = 0.80 p = 0.37; FEP-NA vs SCH - Hemisphere F(1, 120) = 8.5
Please cite this article as: Zuliani, R., et al., Increased gyriﬁcation in schiz
(2017), http://dx.doi.org/10.1016/j.schres.2017.06.060related differences in brain structures have been often observed in sev-
eral neuropsychiatric disorders, including schizophrenia (Ruigrok et al.,
2014; Delvecchio et al., 2017b). Additionally, it might be also plausible
that the different methodological approaches employed by the individ-
ual studies determined these inconsistent results. Indeed, the degree of
methodological heterogeneity is relatively high, with some studies
using manual or automated methods or different number of slices for
calculating and assessing GI. Also, although the majority of the studies
measured GI with a vertex-level approach, some others measured it
across the entire lobe. Indeed, as suggested byNenadic et al. (2015), dif-
ferences in resolution (higher for the vertex-level approach) could ex-
plained the abovementioned differences in GI in schizophrenia.
Interestingly, it is worth mentioning that some of the studies were car-
ried out in multi-affected families (Falkai et al., 2007; Vogeley et al.,
2001) or in high risk individuals (Harris et al., 2004), and they also
found increased GI in ﬁrst-degree relatives of patients with schizophre-
nia (Falkai et al., 2007; Vogeley et al., 2001) and in individuals at high
risk who subsequently develop schizophrenia (Harris et al., 2004).
Therefore, these ﬁndings suggested that increased PFC gyriﬁcation
might be considered a putative endophenotype of schizophrenia and a
predictive vulnerability marker for this disorder. Additionally, based
on the evidence suggesting that GI is amarker that seems to be indepen-
dent from age (Blanton et al., 2001), it might be plausible that might
index an early developmental and a quite possibly genetic anomaly in
neurodevelopment, ultimately explaining its apparent association
with psychosis and schizophrenia.
In general, it has been reported that altered GI in prefrontal regions
in schizophrenia represents an indirect sign of disrupted underlying
connectivity (White and Hilgetag, 2011), which is thought to be deter-
mined by the presence of genetic and environmental risk factors occur-
ring during prenatal, perinatal and early adolescent periods (Harrison,
1999; Hoistad et al., 2009; White and Hilgetag, 2011).
Interestingly, similarly to chronic patients with schizophrenia, we
found that FEP-NA patients showed increased PFC GI compared to HC.
Additionally, it is important noticing that this result was not inﬂuenced
by the presence of a small group of FEP-NA patients who later develop
schizophrenia within our group of FEP-NA patients. Therefore, these
ﬁndings suggest that altered PFC GI can be considered a common bio-
logical substrate characterizing psychosis independently from disease
onset and/or medications. However, to our best knowledge, only
one study investigated the GI in FEP-NA patients and its results are in
contrast with our ﬁndings (Palaniyappan et al., 2013). Indeed,
Palaniyappan et al. (2013) showed that FEP-NA patients had hypogyria
in the PFC. Nonetheless, such discrepancymight be related to the differ-
ent methodological approach employed in this study, which used, in
contrast from our study, a vertex-wise approach across the entire corti-
cal surface. Therefore, further studies investigating GI in FEP patients are
needed in order to better clarify the role of GI in the pathophysiology of
psychosis. Nonetheless, our results further support previous evidence ofd right prefrontal hemispheres and speciﬁed for theﬁrst 30 prefrontal slices. Signiﬁcance of
d HC, FEP-NA and SCH for p b 0.02* (Bonferroni corrected).
ted measures ANOVA
Hemisphere Group × Hemisphere Interaction
3.47, p = 0.03* F(2, 214) = 17.63, p b 0.001* F(2, 214) = 1.4, p = 0.25
ted measures ANOVA
C
of group
SCH vs HC
Main effect of group
FEP-NA vs SCH
Main effect of group
6.13, p = 0.01* F(1, 164) = 10.06, p = 0.00* F(1, 120) = 0.50, p = 0.48
HC = healthy controls. In all the 2 × 2 repeated measures ANOVAs the main effect of the
iﬁcant (all p N 0.5). Themaineffect ofHemisphere and theGroup×Hemisphere interaction
sures ANOVA, with all the models giving signiﬁcant differences between the Hemispheres
sphere F(1, 143) = 0.03, p = 0.87; SCH vs HC - Hemisphere F(1, 164) = 29.36, p b 0.001,
9, p = 0.004, Group × Hemisphere F(1, 120) = 1.47, p = 0.23].
ophrenia and non affective ﬁrst episode of psychosis, Schizophr. Res.
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(2016) showed altered frontal cortex in youth with psychosis spectrum
disorders. Moreover, similarly to schizophrenia, altered structural (Luck
et al., 2011; Price et al., 2008) and functional (Alonso-Solís et al., 2012;
Argyelan et al., 2015; Fornito et al., 2013; Schmidt et al., 2013) PFC con-
nectivity has also been reported for FEP. Therefore, despite the presence
of inconsistencies in the available literature, our study suggests that al-
teredGI and, consequently, disrupted PFC connectivity represents an in-
direct developmental marker for psychosis, overcoming the categorical
diagnosis of schizophrenia (White and Gottesman, 2012), in line with a
dimensional approach as per the Research Domain Criteria approach
(Cuthbert and Insel, 2010).
Furthermore, our results also showed the presence of brain asym-
metry in all our groups, with left PFC having higher GI values compared
to right PFC. Speciﬁcally for HC, ourﬁndings are in linewith previous lit-
erature, reporting functional and structural asymmetries of brain hemi-
spheres in this group of individuals (Chen and Omiya, 2014; Toga and
Thompson, 2003). Interestingly, some studies also reported that HC
had a left N right pattern of PFC gyriﬁcation (Palaniyappan et al., 2011;
Vogeley et al., 2000; Wiegand et al., 2005; Wiegand et al., 2005; Narr
et al., 2004). Therefore, our results further conﬁrmed that brain asym-
metry is an evolutionally adaptive phenomenon occurring in the
human brain, which is associated with normal brain functional/cogni-
tive lateralization.
Similarly, we also observed the presence of the same gyriﬁcation
asymmetry in both FEP-NA and chronic schizophrenia. Interestingly,
this result seems to be in contrast with many functional and structural
MRI studies in schizophrenia, which reported the lack of normal hemi-
sphere asymmetry in this disabling disorder (Ribolsi et al., 2014; Sun et
al., 2017). This lack of normal hemisphere asymmetry is thought to rep-
resent a derailment in the process determining the normal hemispheric
specialization, possibly reﬂecting an altered abnormal underlying brain
connectivity (Oertel-Knöchel and Linden, 2011; Ribolsi et al., 2014;
Mitchell and Crow, 2005). Nevertheless, a similar general consensus
on the abnormalities in gyriﬁcation asymmetry in this patients group
has not been reached yet. Indeed, ﬁndings suggested either a lack or a
reversed pattern of normal gyriﬁcation asimmetry in schizophrenia
(Wiegand et al., 2005; Narr et al., 2004; McIntosh et al., 2009;
Mancini-Marie et al., 2015; Palaniyappan et al., 2011). Therefore, given
the general heterogeneity in GI literature, more research will be useful
for clarifying the role of PFC gyriﬁcation asymmetry in psychosis. Finally,
in our study, no GI differences between individuals with schizophrenia
and FEP-NA patients have been observed and no associations were
found betweenGI and clinical symptoms. Therefore, this result supports
the hypothesis that altered cortical folding is a common biological trait
marker characterizing psychoses, regardless of chronicity, medication,
and illness severity.5. Limitations
This study should be considered in light of few limitations. First,
sample size was relatively small (although in line, or even higher than
studies published so far). Second, patients with schizophrenia were
chronically ill and treated, therefore we cannot fully rule out the possi-
ble role of chronicity and antipsychotic medication in GI alterations.
However, no signiﬁcant correlations were observed between GI and
clinical variables, including length of illness and duration and doses of
antipsychotic treatment. Finally, data on duration of untreated psycho-
sis (DUP) were not available for this study. In general, this clinical mea-
sure was poorly investigated in associationwith GI in psychosis. Indeed,
to the best of our knowledge, only one study, which did not show any
signiﬁcant results, explored the association between DUP and GI in
schizophrenia (Schultz et al., 2010). This negative result is not surpris-
ing especially because previous evidence reported that GI is determined
early in brain development (Zilles et al., 1989) further sustaining thatPlease cite this article as: Zuliani, R., et al., Increased gyriﬁcation in schiz
(2017), http://dx.doi.org/10.1016/j.schres.2017.06.060DUP, and clinical symptoms in general, should have no signiﬁcant ef-
fects on GI patterns.
6. Conclusions
In conclusion, our ﬁndings add further evidence to the existing liter-
ature by showing the presence of a shared aberrant prefrontal GI in
schizophrenia and FEP-NA, thus suggesting that altered GI may repre-
sent a trait marker for psychosis. From this perspective, GI alteration
could be a putative biomarker of psychosis helping for an early detec-
tion of individuals prone to develop psychosis. Nonetheless, future lon-
gitudinal studies coupled with cognitive investigations are expected to
further explore GI in large samples of subjects at risk to develop psycho-
sis followed over time before and after treatment.
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